My interest in haloperidol goes back to April 1964 with the opening of the Psychiatric Department at St Olave's Hospital, Bermondsey. Patients with acute excitement who had previously been admitted directly to Cane Hill Hospital, a mental hospital near Croydon in Surrey, were from that date treated in the psychiatric wards of this general hospital. The wards were open and in an adjoining block to medical and surgical wards so that the need for efficient management of patients with excitement was paramount not only for themselves but also for the wellbeing of adjoining patients and staff in the other medical disciplines.
The rapid control of excitement appeared on clinical grounds to be obtainable by the parenteral administration of major tranquillizing drugs in high dosage. Such medication frequently resulted in untoward drug toxicity, the most dangerous of which, in my view, was that of hypotension. The advantages of haloperidol over other major tranquillizers and hypnotics appeared to be both in regard to safety and to rapidity of action, and its main disadvantage was the production of dystonia. Following upon its synthesis (Janssen et al. 1959 ), Delay and co-workers (1960) reported its effectiveness in the control of psychomotor agitation in a mixed population of psychiatric patients.
Later studies (Danik & Goverdham 1963 , Fitzgerald 1969 in Denmark and in the United Kingdom indicated further the effectiveness with which haloperidol could control the florid symptoms of schizophrenia. In most of these studies, daily dosages of less than 20 mg were used, though doses of up to 200 mg daily had been reported (Kristjansen 1960) . The rapidity with which tranquillity could be produced was discussed by Delay et al. (1960) as varying in the majority of cases between a few hours and two Dr A J P Oldham Consutltant Psychiatrist, Guy's Hospital, London SE], UK days, and from the reports cited there appeared to be some association between the dosage level and the speed of control.
Patients acd Method
The foregoing considerations, coupled with our early clinical experiences, decided Dr M Bott and me to develop a treatment regime involving haloperidol in high dosage. During the years 1964-7, the majority of cases admitted with acute excitement were treated by us with this high dosage treatment and we have reviewed the results in an earlier publication (Oldham & Bott 1971) . The term 'excitement' was used in our study to denote a state of abnormally increased psychomotor activity as judged by one of us at the time of admission. Physical contraindications were unusual, but included cardiovascular disease predisposing the patient to hypotension; hepatic or renal insufficiency; blood dyscrasias and certain other types of organically induced excitement, i.e. thyrotoxicosis, epilepsy or acute infections. While under treatment, the patient was kept in bed continuously or allowed to sit up beside the bed. Daily physical examinations were performed and recordings made of the hours of sleep. Every morning and evening, the blood pressure, temperature, pulse and respiration were recorded. Weekly blood tests were made for the white count and haemoglobin.
Depending upon the patient's age, sex and weight, an initial injection of 10 to 30 mg haloperidol was given, together with daily intramuscular injections of procyclidine hydrochloride. Subsequent doses of haloperidol were either continued at this level or increased, but as soon as tranquillity was achieved, the level of dosage was stabilized. This treatment regime was given for a minimum period of three days and during the three-year study it never exceeded 17 days in all. An optimal eight hours sleep at night was aimed at and nitrazepam was given for this purpose if necessary. The treatment was stopped at once if the systolic blood pressure fell below 100 mmHg, if severe dystonia occurred, or for other physical contraindications. In those cases in which excitement was not controlled, other methods of treatment were adopted. After three or more days, as soon as the excitement had been controlled, the high dosage regime was stopped and haloperidol with orphenadrine hydrochloride was given orally in diminishing dosages. The patient was allowed up progressively and a maintenance regime involving haloperidol in small oral doses was continued in an outpatient clinic or by the patient's general practitioner.
Results
The results of this study were tabulated (Oldham & Bott 1971) . They showed an overall control of excitement in 73 % of patients; partial control in 22 %; and no control in 5 %. Full or partial control was therefore achieved in 95 % of all cases. In 78 % such control was achieved within 72 hours; in 17 % within 73-96 hours; and in 5 % in a longer period. Male patients took longer to control than females, but the number needing longer than 96 hours high dosage treatment was very small. This pattern of control was noted for all diagnoses and in all types of excitement. The control of excitement in patients with diagnosed organic dementia, confusional states and personality disorders was remarkably good, while in other diagnostic categories, full control was achieved in 50-78% of patients. Of the 91 patients fully controlled, 70 received a daily dosage of between 20 and 40 mg haloperidol; 12 received 0-19 mg; six had 40-49 mg and three had 50-79 mg.
Side-effects were surprisingly few, but as stated above, all patients were routinely given anti-parkinsonian drugs so that dystonia, when present, was usually mild in degree. Falls in systolic blood pressure of less than 10 mmHg were considered insignificant and applied to the majority of patients. Falls of 10-20 mmHg occurred in 6 % and falls of over 20 mmHg in 11 % of patients on haloperidol alone, and it was noted that daily dosages of over 50 mg produced such falls in two out of three cases. Falls in systolic blood pressure to below 100 mmHg occurred in 4 cases; in 3 of these it was corrected by lowering the dosage level, while in one the treatment regime had to be abandoned.
Discussion
Since 1967 I have continued to use haloperidol for patients with acute excitement and I therefore have now had clinical experience of it for over ten years. During this time, St Olave's Hospital amalgamated with Guy's and the Psychiatric Unit at St Olave's became responsible for the treatment of adult and geriatric patients with mental illness from the Guy's district population in North Southwark. In this service, cases of excitement could be seen occurring in patients in medical and surgical wards, in the Accident & Emergency Department, or indeed at home. I have continued to find high dosage haloperidol the treatment of preference for acute excitement but I have become aware of certain differential considerations which I would like to discuss.
As I have said above, the great asset of this treatment lies in its speed and relative safety and its main disadvantage in the production of extrapyramidal side-effects. The risk that parkinsonism, once induced in the senile or arteriosclerotic brain, may persist after withdrawal of the causative drug, must be borne in mind and over the years I have seen several of such cases. In these, it was not possible to say that parkinsonism would not have occurred if haloperidol or other drug had not been given and the number was very small compared to all the patients I have treated. It has, however, inclined me against prescribing to such patients any of the major tranquillizers, including haloperidol, which have extrapyramidal side-effects in therapeutic dosage.
A further limitation on high dosage haloperidol treatment lies in its nursing and medical requirements. To be given effectively, in my experience the doctors and nurses involved need to know the regime well and preferably to have had previous experience in it. Generations of registrars coming to work at St Olave's have sometimes found the treatment of little clinical value until, after discussion, the importance of such factors as adequate dosage and sleep control have been assessed and catered for in the clinical usage of the drug. However, the need for this doctornurse expertise has largely led to my discontinuing the drug in domiciliary therapy. In our service we have available trained psychiatric nurses based at St Olave's who visit selected patients in their homes and treat them on our prescription. In this situation, in which the nurse only visits the patient perhaps once a day, the type of treatment regime I have described is not effective. But in the Accident & Emergency Department at Guy's, where we have a service based upon casualty officers with a back-up of psychiatric registrars, I have found the initiation of this treatment both practicable and effective.
In every hospital the Casualty Department is where many excited patients attend. In the past, in our service many such patients, after medical examination, have had admission to a psychiatric ward arranged without any associated emergency treatment. The result of this can be a patient disturbing to the Casualty Department, the ambulance crew and to the psychiatric ward where he duly arrives for admission. Such disturbance may result in physical and psychological trauma, both to the patient and to those around him, and the ward where he is admitted, if at night, may well remain disturbed until the next morning. In such cases, the haloperidol treatment can, with benefit, be started in Casualty where the initial intramuscular injection is given. If the patient is then allowed to rest for 15-30 minutes, a degree of tranquillity will usually follow so that the subsequent admission can be achieved without the distress I have mentioned. Good liaison between the psychiatric registrars in Casualty and the medical staff of the admitting ward is essential and at Guy's we have made a practice of discuss-ing such cases in retrospect at a special psychiatric weekly meeting in Casualty.
Given all these considerations, I continue to find haloperidol used in this manner the best way of treating the majority of cases of acute excitement in the psychiatric wards. In some cases, twice-daily injections seem more effective and in most an adequate initial dose is essential. For a male adult of average build I usually commence with 30 mg i.m. raising the dose by 10 mg daily until the excitement is controlled. Prescribed in this way, and by ensuring eight hours of sleep charted and supervized by the nursing staff at night, it has been my experience that the top dosage has seldom needed to be much above 60 mg per day. The incidence of uncontrollable extrapyramidal side-effects has accordingly been small (Oldham & Bott 1971 ).
Conclusion
In this paper I have described my experiences of haloperidol given in high dosage for excitement. What I have said applies only to this and has no bearing on the application of the drug to other clinical states, whether as a form of initial treatment or of maintenance therapy. As a hospital treatment for acute excitement, however, haloperidol in high dosage is probably the quickest, safest and surest method of control and is one in which every general hospital psychiatric department should become skilled.
